Literature DB >> 4123858

Androgenic-anabolic steroid therapy and hepatocellular carcinoma.

J T Henderson, J Richmond, M D Sumerling.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4123858     DOI: 10.1016/s0140-6736(73)91384-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Benign liver cell adenoma associated with use of oral contraceptive agents.

Authors:  S Baek; C E Sloane; S C Futterman
Journal:  Ann Surg       Date:  1976-03       Impact factor: 12.969

Review 2.  Adverse effects of anabolic steroids.

Authors:  R C Hickson; K L Ball; M T Falduto
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Jul-Aug

3.  Androgen associated hepatocellular carcinoma with an aggressive course.

Authors:  D Gleeson; M J Newbould; P Taylor; R F McMahon; B C Leahy; T W Warnes
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

Review 4.  Recent developments in the toxicology of anabolic steroids.

Authors:  S Graham; M Kennedy
Journal:  Drug Saf       Date:  1990 Nov-Dec       Impact factor: 5.606

Review 5.  Hepatitis B virus infection and primary hepatocellular carcinoma.

Authors:  M Feitelson
Journal:  Clin Microbiol Rev       Date:  1992-07       Impact factor: 26.132

Review 6.  [Liver and ovulation inhibitors. Effects on liver function of estrogen-progestagen containing steroid oral contraceptives].

Authors:  J Eisenburg; W Kruis; M Weinzierl; U Scherer
Journal:  Naturwissenschaften       Date:  1979-10

7.  Hepatic lesions in patients treated with synthetic anabolic steriods.

Authors:  E C Sweeney; D J Evans
Journal:  J Clin Pathol       Date:  1976-07       Impact factor: 3.411

Review 8.  The anabolic androgenic steroid oxandrolone in the treatment of wasting and catabolic disorders: review of efficacy and safety.

Authors:  Rhonda Orr; Maria Fiatarone Singh
Journal:  Drugs       Date:  2004       Impact factor: 9.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.